NATCO PHARMA LTD. - United States PTO Rejects Teva's '808 Patent Reissue Application on Copaxone(R) for the Second Time

Natco Pharma Ltd has informed BSE regarding a Press Release dated April 04, 2014 titled "United States PTO Rejects Teva's '808 Patent Reissue Application on Copaxone(R) for the Second Time".